Artelo Biosciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARTL and other ETFs, options, and stocks.

About ARTL

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. 

CEO
Gregory D. Gorgas
CEOGregory D. Gorgas
Employees
5
Employees5
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2011
Founded2011
Employees
5
Employees5

ARTL Key Statistics

Market cap
7.45M
Market cap7.45M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
20.34K
Average volume20.34K
High today
$2.61
High today$2.61
Low today
$2.57
Low today$2.57
Open price
$2.57
Open price$2.57
Volume
19.97K
Volume19.97K
52 Week high
$11.07
52 Week high$11.07
52 Week low
$2.38
52 Week low$2.38

ARTL Earnings

-$5.70
-$3.80
-$1.90
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Estimated— per share
Actual
Expected Feb 28, Pre-Market
ActualExpected Feb 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.